Biopsy Devices | Medtech 360 | Market Insights | Europe

Publish date: May 2017

Login to access report

The European biopsy device market will grow modestly through 2025. Market expansion will be driven in part by revenue growth in the percutaneous soft tissue biopsy device segment, which is the fastest-growing market due to increased breast cancer screening in the region, which is driving breast biopsy procedure volumes. Additionally, a high volume of PSA-based screening tests are performed in Europe, contributing to growth in the number of prostate biopsies performed, further supporting revenue growth in the overall market.

Within the nonbreast indications, prostate biopsy and lung biopsy volumes are the highest in Europe, and changes in procedure volumes in these indications will have the largest effect on total nonbreast soft tissue biopsy volumes. This is because the incidence of liver cancer is much lower in Europe than in the US due to a lower level of infections from hepatitis in the former region (Hepatocellular Carcinoma. Decision Resources Group. Epidemiology, 2017).

Low participation in certain cancer screening programs, such as those for breast cancer and CRC, has been a concern among health authorities in Europe, and they are now considering offering invitation-based screening programs to bolster participation. Increases in screening participation as a result of such initiatives will boost biopsy procedure volumes over the forecast period.

Table of contents

  • Europe
    • Executive Summary
      • Market Highlights
      • Competitive Highlights
      • Market Developments
      • Geographies Covered
      • Procedures Covered
      • Products Covered
    • Version History
    • Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Competitive Landscape
      • Market Developments
    • Percutaneous Soft Tissue Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Vacuum-Assisted Biopsy Devices
        • Core Needle Biopsy Devices
        • Fine Needles
      • Competitive Highlights
      • Competitive Landscape
      • Market Share Ranking
    • Gastrointestinal Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
        • Polypectomy Snares
      • Competitive Highlights
      • Market Shares
    • Bronchial Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
        • Biopsy Forceps
        • TBNA Needles
      • Competitive Highlights
      • Major Competitors
    • Gynecological Biopsy Device Market
      • Market Highlights
      • Market Definitions
      • Market Forecast Data
      • Competitive Highlights
      • Major Competitors
    • Appendix
      • Abbreviations
      • Bibliography

Author(s): Aditya Acharya, MPharm

Aditya Acharya is an analyst within the Endoscopy and Aesthetics Medtech Insights team at Decision Resources Group, specializing in the biopsy device market. Aditya holds a Bachelor's degree in Pharmacy from Poona College of Pharmacy (Bharati Vidyapeeth University) and a Master's degree in Industrial Pharmacy from JSS University.